Dr. Michael Siegal, MD

NPI: 1659434520
Total Payments
$38,372
2019 Payments
$5,934
Companies
3
Transactions
38
Medicare Patients
108
Medicare Billing
$8,306

Payment Breakdown by Category

Consulting$31,836 (83.0%)
Travel$5,616 (14.6%)
Food & Beverage$920.29 (2.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $31,836 6 83.0%
Travel and Lodging $5,616 12 14.6%
Food and Beverage $920.29 20 2.4%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $22,671 25 $0 (2019)
Janssen Scientific Affairs, LLC $8,692 7 $0 (2018)
Novartis Pharmaceuticals Corporation $7,009 6 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2019 $5,934 7 Janssen Pharmaceuticals, Inc ($5,934)
2018 $8,692 7 Janssen Scientific Affairs, LLC ($8,692)
2017 $23,747 24 Janssen Pharmaceuticals, Inc ($16,737)

All Payment Transactions

38 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/02/2019 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Travel and Lodging In-kind items and services $623.83 General
Category: Cardiovascular & Metabolism
08/02/2019 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Travel and Lodging Cash or cash equivalent $79.67 General
Category: Cardiovascular & Metabolism
07/12/2019 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Consulting Fee Cash or cash equivalent $5,100.00 General
Category: Cardiovascular & Metabolism
06/14/2019 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Cardiovascular & Metabolism
06/14/2019 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $35.00 General
Category: Cardiovascular & Metabolism
06/14/2019 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $30.00 General
Category: Cardiovascular & Metabolism
06/14/2019 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: Cardiovascular & Metabolism
03/17/2018 Janssen Scientific Affairs, LLC INVOKANA (Drug) Consulting Fee Cash or cash equivalent $6,700.00 General
Category: Cardiovascular & Metabolism
03/17/2018 Janssen Scientific Affairs, LLC INVOKANA (Drug) Travel and Lodging Cash or cash equivalent $1,362.74 General
Category: Cardiovascular & Metabolism
03/17/2018 Janssen Scientific Affairs, LLC INVOKANA (Drug) Travel and Lodging In-kind items and services $389.17 General
Category: Cardiovascular & Metabolism
03/17/2018 Janssen Scientific Affairs, LLC INVOKANA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular & Metabolism
03/17/2018 Janssen Scientific Affairs, LLC INVOKANA (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Cardiovascular & Metabolism
03/17/2018 Janssen Scientific Affairs, LLC INVOKANA (Drug) Food and Beverage In-kind items and services $35.00 General
Category: Cardiovascular & Metabolism
03/17/2018 Janssen Scientific Affairs, LLC INVOKANA (Drug) Food and Beverage In-kind items and services $30.00 General
Category: Cardiovascular & Metabolism
12/20/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Consulting Fee Cash or cash equivalent $2,400.00 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Consulting Fee Cash or cash equivalent $5,601.00 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Travel and Lodging In-kind items and services $609.79 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Travel and Lodging Cash or cash equivalent $166.12 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $35.53 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $35.00 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $30.00 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: Cardiovascular & Metabolism
12/04/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: Cardiovascular & Metabolism
07/14/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Travel and Lodging In-kind items and services $779.89 General
Category: Cardiovascular & Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 11 13 $2,157 $1,691
2022 2 31 42 $4,655 $3,334
2021 1 11 14 $140.00 $42.00
2020 4 55 61 $4,289 $3,238
Total Patients
108
Total Services
130
Medicare Billing
$8,306
Procedure Codes
8

All Medicare Procedures & Services

8 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 11 13 $2,157 $1,691 78.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 17 26 $4,337 $3,154 72.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 14 16 $318.72 $180.11 56.5%
36415 Insertion of needle into vein for collection of blood sample Office 2021 11 14 $140.00 $42.00 30.0%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 16 20 $3,336 $2,577 77.3%
94010 Measurement and graphic recording of total and timed exhaled air capacity Office 2020 12 12 $514.32 $388.15 75.5%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 14 15 $298.80 $230.69 77.2%
36415 Insertion of needle into vein for collection of blood sample Office 2020 13 14 $140.00 $41.94 30.0%

About Dr. Michael Siegal, MD

Dr. Michael Siegal, MD is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659434520.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Siegal, MD has received a total of $38,372 in payments from pharmaceutical and medical device companies, with $5,934 received in 2019. These payments were reported across 38 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($31,836).

As a Medicare-enrolled provider, Siegal has provided services to 108 Medicare beneficiaries, totaling 130 services with total Medicare billing of $8,306. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Location New York, NY
  • Active Since 12/19/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1659434520

Products in Payments

  • INVOKANA (Drug) $31,363
  • SERELAXIN (Drug) $7,009

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in New York